Randomized phase I and pharmacological study of weekly or 2-weekly gemcitabine and cisplatin in advanced non-small cell lung cancer

Documenti analoghi

• Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours
  di: Siegel-Lakhai, W S, et al.
  Pubblicazione: (2005)
• Motilin kinetics and effects on proximal stomach in patients with functional dyspepsia (FD) and healthy volunteers
  di: Kamerling, I, et al.
  Pubblicazione: (2002)
• A recirculatory model for tissue plasminogen activator with saturable endothelial binding
  di: Kemme, M J B, et al.
  Pubblicazione: (2002)
• Concurrent Chemoradiation With Weekly Gemcitabine and Cisplatin in Locally Advanced Cervical Cancer
  di: Esmati E, et al.
  Pubblicazione: (2011-12-01)
• Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer
  di: van der Noll, R., et al.
  Pubblicazione: (2015)